Trading update
Logotype for Spirax Group plc

Spirax Group (SPX) Trading update summary

Event summary combining transcript, slides, and related documents.

Logotype for Spirax Group plc

Trading update summary

11 Nov, 2026

Group performance and outlook

  • Organic sales growth and adjusted operating profit margin for the 10 months to October were in line with expectations and ahead of H1; Together for Growth continued to drive growth.

  • FY guidance reaffirmed: mid-single-digit organic Group revenue growth and adjusted operating profit margin above the 2025 level of 20.0%.

  • STS FY margin expected broadly in line with 2025; medium-term targets set in 2024 remain on track.

  • FY cash conversion expected at ~90%.

Segment trading

  • STS organic sales growth accelerated in the four months to October, supported by June-end orderbook shipments and continued order momentum; H2 margin expected ahead of H1.

  • STS China MRO growth is double-digit; large-project declines are moderating, and China sales are on track to match 2025 for the full year.

  • ETS sustained strong H1 organic sales growth; Process Heating and Heat Trace order intake remained strong, and Equipment Heating benefited from higher Semicon demand. Growth excluding Semicon remains above the mid-single-digit medium-term target.

  • ETS operational gearing and manufacturing efficiencies are expected to support a higher H2 margin than H1.

  • WMFTS Biopharm and Process Industries sales growth strengthened; orders remained ahead of Biopharm sales, with H2 growth expected to lift margin slightly above H1.

Financial position

  • Net borrowings excluding leases were £541.6m at 31 October, down from £618.2m at 30 June; net debt to EBITDA was 1.3x, versus 1.6x.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Spirax Group